Skip to content
  • Investors
  • News & Events
  • Contact Us
Rigel Pharmaceuticals
  • Who We Are
  • Pipeline
  • Products
  • Join Our Team
  • Investors
  • News
  • Contact Us
Rigel Pharmaceuticals
  • Who We Are
  • Pipeline
  • Products
  • Join The Team
  • Investors
  • News
  • Contact Us
Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • FAQ
  • Stock Data
    • Stock Quote
    • Charting
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Analyst Coverage
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

  • News & Events

  • Press Releases
  • Events & Presentations
  • Email Alerts

Rigel to Present at Two Upcoming Investor Conferences

Sep 09, 2020 7:30am EDT

Rigel to Participate in Citi's 15th Annual BioPharma Virtual Conference

Sep 02, 2020 7:30am EDT

Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program

Aug 04, 2020 4:01pm EDT

Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update

Jul 28, 2020 7:30am EDT

Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology

Jul 27, 2020 7:30am EDT

Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia

Jul 14, 2020 7:30am EDT

Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe

Jul 09, 2020 8:19am EDT

Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference

Jun 17, 2020 7:30am EDT

Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress

Jun 11, 2020 7:30am EDT

Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress

Jun 03, 2020 7:30am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...31
    Next
    • Email Alerts
    • Tear Sheet
    • RSS News Feed
    • Terms of Use
    • Privacy Policy

    © 2021 Rigel Pharmaceuticals, Inc. All rights reserved.
    TAVALISSE and the Rigel arc logo are trademarks of Rigel Pharmaceuticals, Inc.
    TAVA_ITP-19277

    • facebook
    • twitter
    • linkedin
    © 2021 Rigel Pharmaceuticals • Powered by GeneratePress